Clinical Trial Update: Study of Cetuximab With Concomitant-boost Radiotherapy in Patients With Newly Diagnosed Locally Advanced Squamous Cell Carcinoma of the Head and Neck (SCCHN) [Phase 2]

View source ↗

Summary

Phase 2 study evaluating cetuximab plus concomitant-boost radiotherapy in newly diagnosed locally advanced head and neck squamous cell carcinoma; results were p…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Head and Neck Squamous Cell Carcinoma

Drugs mentioned

• Erbitux (cetuximab) (cetuximab)

Snippet

Sponsor: Merck KGaA, Darmstadt, Germany | Conditions: Carcinoma of the Head and Neck | Phase 2 | Status: COMPLETED | Results posted: 2011-07-22